We are developing a fourth generation nanopore sensor for ultra-fast genome sequencing, funded by NIH under the $1000 genome program. Our aim is to produce a sequencer capable of sequencing the whole genome in 15 minutes, costing only $100. Our first-to-market product is a cancer drug discovery and diagnostics platform. We are raising Series-A financing to develop the genome sequencer prototype and cancer drug discovery and diagnostics system.